# COVID-19 Vaccine Reactogenicity and Immunogenicity

> **NCT05258708** · — · UNKNOWN · sponsor: **Korea University Guro Hospital** · enrollment: 179 (estimated)

## Conditions studied

- COVID-19
- Vaccine Immune Response
- Vaccine Adverse Reaction

## Interventions

- **BIOLOGICAL:** mRNA-1273 COVID-19 vaccine

## Key facts

- **NCT ID:** NCT05258708
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-24
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 179 (ESTIMATED)
- **Last updated:** 2022-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258708, "COVID-19 Vaccine Reactogenicity and Immunogenicity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05258708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*